Ultrasound versus Conventional Treat-To-Target Strategies in Early Rheumatoid Arthritis: Magnetic Resonance Imaging Outcome Data from a 2-year Randomized Controlled Strategy Trial

被引：0
|
作者：
Sundin, Ulf [1 ,2 ]
Aga, Anna-Birgitte [1 ]
Skare, Oivind [1 ]
Nordberg, Lena [1 ]
Uhlig, Till [3 ]
Hammer, Hilde [1 ]
van der Heijde, Desiree [4 ]
Kvien, Tore [3 ]
Lillegraven, Siri [1 ]
Haavardsholm, Espen [3 ]
机构：
[1] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway
[2] Univ Oslo, Oslo, Norway
[3] Univ Oslo, Diakonhjemmet Hosp, Dept Rheumatol, Fac Med, Oslo, Norway
[4] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0280
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Similar lipid level changes in early rheumatoid arthritis patients following 1-year treat-to-target strategy with adalimumab plus methotrexate versus placebo plus methotrexate: secondary analyses from the randomised controlled OPERA trial
    Masic, Dzenan
    Stengaard-Pedersen, Kristian
    Logstrup, Brian Bridal
    Horslev-Petersen, Kim
    Hetland, Merete Lund
    Junker, Peter
    ostergaard, Mikkel
    Ammitzboll, Christian
    Moller, Soren
    Christensen, Robin
    Ellingsen, Torkell
    RHEUMATOLOGY INTERNATIONAL, 2021, 41 (03) : 543 - 549
  • [22] An MRI Guided Treat-to-Target Strategy in Rheumatoid Arthritis Patients in Clinical Remission Improved MRI Inflammation but Not Damage Progression - Results from the Imagine-RA Randomized Controlled Trial
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Ejbjerg, Bo Jannik
    Glinatsi, Daniel
    Hetland, Merete Lund
    Ornbjerg, Lykke
    Moller, Jakob M.
    Boesen, Mikael
    Christensen, Robin
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen-Margrethe
    Bennett, Philip
    Hendricks, Oliver
    Asmussen, Karsten
    Kowalski, Marcin Ryszard
    Lindegaard, Hanne
    Nielsen, Sabrina Mai
    Bliddal, Henning
    Krogh, Niels Steen
    Ellingsen, Torkell
    Nielsen, Agente
    Balding, Lone
    Jurik, Anne Grethe
    Thomsen, Henrik S.
    Ostergaard, Mikkel
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [23] Long-term Efficacy of a 2-year MRI Treat-to-target Strategy on Radiographic Joint Damage Progression in Rheumatoid Arthritis Patients in Clinical Remission - Five Year Follow-up of the IMAGINE-RA Randomized Clinical Trial
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Ornbjerg, Lykke
    Ejbjerg, Bo
    Hetland, Merete L.
    Moeller, Jakob
    Christensen, Robin
    Nielsen, Sabrina Mai
    Glinatsi, Daniel
    Boesen, Mikael
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen-Margrethe
    Hendricks, Oliver
    Lindegaard, Hanne Merete
    Krogh, Niels Steen
    Jurik, Anne Grethe
    Thomsen, Henrik
    Ostergaard, Mikkel
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3701 - 3703
  • [24] Induction Therapy With Adalimumab On Top Of An Aggressive Treat-To-Target Strategy With Methotrexate and Intraarticular Corticosteroid Reduces Radiographic Erosive Progression In Early Rheumatoid Arthritis, Even After Withdrawal Of Adalimumab. Results Of a 2-Year Trial (OPERA).
    Horslev-Petersen, Kim
    Ornbjerg, Lykke Midtboll
    Hetland, Merete L.
    Junker, Peter
    Podenphant, Jan
    Ellingsen, Torkell
    Ahlqvist, Palle
    Lindegaard, Hanne M.
    Linauskas, Asta
    Schlemmer, Annette
    Dam, Mette Y.
    Hansen, Ib
    Lottenburger, Tine
    Jorgensen, Anette
    Krintel, Sophine B.
    Raun, Johnny
    Ammitzboll, Christian G.
    Johansen, Julia
    Ostergaard, Mikkel
    Stengaard-Pedersen, Kristian
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S600 - S601
  • [25] Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-target strategy for early rheumatoid arthritis
    Besselink, N. J.
    Westgeest, A. A. A.
    Klaasen, R.
    Gamala, M.
    van Woerkom, J. M.
    Tekstra, J.
    Verhoeven, M. M. A.
    Van Spil, W. E.
    Lafeber, F. P. J. G.
    Marijnissen, A. C. A.
    Van Laar, J. M.
    Jacobs, J. W. G.
    TRIALS, 2019, 20 (1)
  • [26] Novel optical spectral transmission (OST)-guided versus conventionally disease activity-guided treatment: study protocol of a randomized clinical trial on guidance of a treat-to-target strategy for early rheumatoid arthritis
    N. J. Besselink
    A. A. A. Westgeest
    R. Klaasen
    M. Gamala
    J. M. van Woerkom
    J. Tekstra
    M. M. A. Verhoeven
    W. E. Van Spil
    F. P. J. G. Lafeber
    A. C. A. Marijnissen
    J. M. Van Laar
    J. W. G. Jacobs
    Trials, 20
  • [27] 10+Years' Follow-up of a Danish 2-Year Treat-to-Target RCT in Patients with Early Rheumatoid Arthritis: Baseline Predictors of Functional and Radiographic Outcomes
    Hetland, Merete Lund
    Stengaard-Pedersen, Kristian
    Junker, Peter
    Lindegaard, Hanne
    Ellingsen, Torkell
    Podenphant, Jan
    Skojdt, Henrik
    Vestergaard, Aage
    Ejbjerg, Bo Jannik
    Jacobsen, Soren
    Krogh, Niels Steen
    Ostergaard, Mikkel
    Horslev-Petersen, Kim
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [28] Treat-to-Target Approaches in Early Psoriatic Arthritis: Early Secukinumab versus Standard Care-12-and 24-Week Results from a Multicenter, Open-Label, Randomized Controlled Trial
    Koc, Gonul Hazal
    Kok, Marc R.
    Kasiem, Fazira R.
    Luime, Jolanda
    Tchetverikov, Ilja
    Wilhelm-de Jong, Kim
    Korswagen, Lindy A.
    Bijsterbosch, Jessica
    Goekoop-Ruiterman, Yvonne P. M.
    Baudoin, Paul
    Kok, Petra
    Bos, Reinhard
    Dolhain, Radboud J. E. M.
    Vis, Marijn
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2956 - 2959
  • [29] Effect of a treat-to-target strategy based on methotrexate and intra-articular betamethasone with or without additional cyclosporin on MRI-assessed synovitis, osteitis, tenosynovitis, bone erosion, and joint space narrowing in early rheumatoid arthritis: results from a 2-year randomized double-blind placebo-controlled trial (CIMESTRA)
    Moller-Bisgaard, S.
    Ejbjerg, B. J.
    Eshed, I.
    Horslev-Petersen, K.
    Hetland, M. L.
    Jurik, A. G.
    Thomsen, H.
    Torfing, T.
    Stengaard-Pedersen, K.
    Junker, P.
    Krogh, N. S.
    Lottenburger, T.
    Ellingsen, T.
    Andersen, L. S.
    Skjodt, H.
    Svendsen, A. J.
    Tarp, U.
    Hansen, I. T.
    Podenphant, J.
    Pedersen, J. K.
    Lindegaard, H.
    Hanson, L. G.
    Vestergaard, A.
    Glinatsi, D.
    Ostergaard, M.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (05) : 335 - 345
  • [30] THE VALUE OF ADDING MRI TO A CLINICAL TREAT-TO-TARGET STRATEGY IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL REMISSION: CLINICAL AND RADIOGRAPHIC OUTCOMES FROM THE IMAGINE-RA RANDOMISED CONTROLLED TRIAL
    Moller-Bisgaard, S.
    Horslev-Pedersen, K.
    Ejbjerg, B.
    Hetland, M.
    Ornbjerg, L.
    Glinatsi, D.
    Moller, J.
    Boesen, M.
    Christensen, R.
    Stengaard-Pedersen, K.
    Madsen, O. R.
    Jensen, B.
    Villadsen, J.
    Hauge, E-M.
    Bennett, P.
    Hendricks, O.
    Asmussen, K.
    Kowalski, M.
    Lindegaard, H.
    Nielsen, S. M.
    Bliddal, H.
    Krogh, N.
    Ellingsen, T.
    Nielsen, A. H.
    Balding, L.
    Jurik, A. G.
    Thomsen, H.
    Ostergaard, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 58 - 59
12345